Advertisements

Amizin (Azithromycin)

Quick links to important sections

Amizin (Azithromycin)

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Amizin (Azithromycin)

Quick Facts: Amizin (Azithromycin)

Property Description
Active Ingredient Azithromycin
Common Forms Tablets, Capsules, Oral Suspension
Pharmacological Class Macrolide/Azalide Antibiotic
Origin Semi-synthetic
General Purpose To neutralize bacterial infections

What Type of Medicine is Amizin (Azithromycin) and What is its Purpose?

Amizin is a prescription medicine defined by its active ingredient, Azithromycin, and is officially classified as a broad-spectrum antibiotic used to combat bacterial infections where the organism is susceptible. Azithromycin belongs to the azalide subclass of macrolide antibiotics, a group clinically recognized for its distinctive pharmacokinetic profile. This drug is a semi-synthetic compound, meaning its structure was chemically altered from the naturally occurring macrolide Erythromycin to improve stability. This modification enables its characteristic long half-life and significant ability to achieve high tissue penetration.

Azithromycin: Composition, Forms, and Origin

The composition of Amizin is centered on Azithromycin as the single active ingredient. This drug is distinguished by its enhanced acid-stability compared to first-generation macrolides. Amizin is manufactured in several principal dosage forms, including tablets, capsules, and preparations for oral suspension, allowing for the primary oral route of administration. Formulations for intravenous infusion are also available for settings requiring rapid systemic delivery in serious infections.

Core Action: How Azithromycin Targets Bacterial Growth

Azithromycin's core action is centered on disrupting the growth and spread of target bacteria by interfering with the process known as protein synthesis. The drug achieves this by binding to the 50S subunit of the bacterial ribosome, which halts the bacteria's ability to construct the proteins required for replication. This mechanism of action is pharmacologically supported as key to suppressing the bacterial population. The resulting clinical benefit is the effective neutralization of the bacterial population, which enables the body's immune system to clear the established bacterial infection.

Regulatory References

  1. EMA Azithromycin Public Health Review
Advertisements

What side effects are possible with Amizin (Azithromycin)?

Possible Side Effects and Safety Information

The safety profile for Azithromycin is established by official regulatory documents, which categorize potential adverse reactions based on how frequently they have been documented. Side effects are also classified according to the specific System-Organ Classes (SOCs) they affect, such as Gastrointestinal Disorders, Nervous System Disorders, and Hepatobiliary Disorders.

Frequency-Classified Adverse Reactions

Classification Examples of Reactions
Very Common Diarrhea, Abdominal pain, Nausea.
Common Vomiting, Headache, Dizziness, Rash, Fatigue.
Uncommon Candidiasis, Hypersensitivity, Palpitations, Hepatitis, Photosensitivity.

Serious Adverse Reactions

Regulatory labeling specifies risks of certain serious, though less frequent, adverse reactions. These include the potential for Hepatotoxicity (severe liver damage, sometimes fatal, including cholestatic jaundice) and significant Cardiovascular Events, specifically QT interval prolongation and the associated risk of a life-threatening ventricular arrhythmia called Torsade de Pointes. Severe, sometimes fatal, skin reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are also officially documented. Furthermore, Clostridioides difficile associated diarrhea (CDAD) is a possibility, which may occur even up to two months after treatment is finished.


Safety Considerations and Restrictions

Azithromycin is contraindicated in patients with a known hypersensitivity to azithromycin, erythromycin, or any macrolide or ketolide antibiotic. Caution is advised for specific populations: those with severe renal impairment or a pre-existing history of cholestatic jaundice. Older adults may be more susceptible to the cardiac risk of QT prolongation. In neonates (infants up to 42 days old), there have been reports of Infantile Hypertrophic Pyloric Stenosis (IHPS), a condition affecting the stomach.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Azithromycin overdose focuses on documented manifestations and the mandatory emergency response.

Overdosage is typically reported to present with an exaggeration of known adverse reactions, primarily including severe nausea, vomiting, and diarrhea. The most serious risk documented in regulatory labeling is the potential for cardiovascular toxicity, specifically the prolongation of the QT interval, which can lead to life-threatening ventricular arrhythmias such as Torsades de pointes.

Due to the potential for fatal cardiac events, regulatory authorities mandate that immediate medical attention must be sought if an overdose is suspected. Patients are required to immediately call a poison control center or emergency room.

Management described in official documents is non-specific, noting that no specific antidote is known. Overdose management consists of general symptomatic and supportive measures. Activated charcoal may be administered to assist in reducing the systemic absorption of the drug, and continuous monitoring of cardiovascular stability may be required.

Advertisements

Therapeutic Uses of Amizin (Azithromycin)

What Amizin (Azithromycin) Treats: Main Uses and Benefits

Azithromycin is commonly used to help with a range of bacterial infections. It is relevant when symptoms are related to inflammatory or irritative states caused by susceptible bacteria. In clinical practice, the medication is generally applied in contexts involving acute or disruptive symptom patterns across several therapeutic domains.

This includes managing conditions such as Community-Acquired Pneumonia, acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, uncomplicated skin and soft tissue infections, Acute Otitis Media, and certain Sexually Transmitted Diseases like chlamydia. The medication is commonly used when symptoms intensify, requiring short-term symptomatic assistance.

The medication provides support that helps ease the overall symptom load during difficult episodes. As one patient experience may be described:

“It may provide support that assists in easing the overall symptom burden when symptoms become more noticeable.”

It contributes to improved comfort during periods of heightened symptoms, which may help patients cope more steadily with symptom fluctuations.


Quick Fact: Symptomatic Domains

Symptom Domain Key Conditions Managed Therapeutic Benefit
Respiratory/Ear Pneumonia, Sinusitis, Otitis Media May assist with managing symptoms related to physical discomfort.
Dermatological Cellulitis, Impetigo Is relevant for managing symptoms related to inflammatory states.
Opportunistic MAC Disease, Chlamydia Contributes to easing the overall symptom load associated with distress.

Regulatory References

  1. FDA Label for AZITHROMYCIN Tablets
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Azithromycin — Official Regulatory Information

Eligibility Scope Classification and Rule Status
Hypersensitivity Known allergy to Azithromycin, Erythromycin, or any Macrolide/Ketolide drug. Contraindicated
Prior Hepatic Dysfunction History of cholestatic jaundice or hepatic dysfunction associated with previous azithromycin use. Contraindicated
Pediatric Use Safety and effectiveness in patients under 6 months of age for most indications. Use Not Established
Organ Function Patients with severe hepatic impairment (Child-Pugh Class C) or severe renal impairment (GFR < 10 mL/min). Use with Caution / Not Recommended
Cardiac Conditions Known QT interval prolongation or ongoing proarrhythmic conditions (e.g., clinically significant bradycardia). Use with Caution
Comorbidity Risk Patients with Myasthenia Gravis or patients receiving ergot derivatives (e.g., ergotamine). Use with Caution / Contraindicated
Reproductive Status Use during Pregnancy or Lactation (excreted in breast milk). Avoided / Not Recommended

Official regulatory documents define patient eligibility through absolute contraindications related to prior drug hypersensitivity or past severe hepatic injury from azithromycin. Beyond these exclusions, the medicine requires caution in populations with specific physiological risks, including severe compromise of the liver or kidneys, certain cardiac disorders, and pre-existing Myasthenia Gravis. Use in infants under six months of age is generally classified as not established by regulators.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Unlike other macrolide antibiotics, Azithromycin exhibits limited interaction with the cytochrome P450 (CYP) enzyme system in the liver, meaning it does not significantly inhibit the metabolism of many medicines. However, it is an inhibitor and substrate of the drug transporter P-glycoprotein (P-gp).

Clinically significant interactions requiring caution or monitoring include:

  • Medicines that prolong the QT interval: Co-administration with other drugs known to prolong the QT interval, such as certain antiarrhythmics (e.g., amiodarone, sotalol), antipsychotics, and some antidepressants (e.g., citalopram), can increase the risk of serious irregular heart rhythms (torsades de pointes).
  • P-glycoprotein substrates: Azithromycin may increase the plasma concentration of certain P-gp substrate medicines, such as digoxin and colchicine, potentially leading to enhanced effects or toxicity. Close monitoring of blood levels or signs of toxicity is recommended.
  • Anticoagulants (e.g., Warfarin): While official data is conflicting, there have been reports that azithromycin can enhance the effect of oral anticoagulants, increasing the risk of bleeding. Close monitoring of coagulation parameters is advisable.
  • Antacids: Concomitant use of aluminum- or magnesium-containing antacids can reduce the peak concentration of azithromycin, decreasing its absorption and potentially its effectiveness. A timing-based separation of at least two hours between taking azithromycin and these antacids is necessary.
  • Nelfinavir: Co-administration of the HIV medicine nelfinavir leads to increased serum concentrations of azithromycin. Close monitoring for known adverse reactions of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted.
Advertisements

Mechanism of Action

Targeting Bacterial Protein Synthesis

Azithromycin binds specifically to the 50S ribosomal subunit inside susceptible bacterial cells, functioning as a protein synthesis inhibitor. This molecular interaction inhibits the translation process by blocking the polypeptide exit tunnel, which limits the bacteria's ability to assemble proteins essential for cellular function and division. This consequent inhibition of translation results in the arrest of bacterial replication, leading to a suppression of the susceptible pathogen population.


Sustained Localized Action

A separate mechanistic domain involves the compound's high affinity for and sequestration within certain immune cells (specifically phagocytes). These cells enable a drug-transport mechanism, allowing the compound to accumulate at the site of microbial presence. This distribution pattern facilitates an extended duration of the mechanism's action on the susceptible pathogen population.

Advertisements

Dosage and Administration Information

How to Use Amizin (Azithromycin)

Azithromycin usage is defined by clinical guidelines to facilitate consistent administration across its various forms and regimens. The medicine is primarily administered via the oral route (tablets, capsules, or suspension) or the intravenous (IV) route for initial therapy in specific severe infections.

Administration and Timing

Most multi-day oral courses are administered once daily. Common adult regimens include a 5-day course (e.g., 500 mg on Day 1, followed by 250 mg on Days 2–5) or an alternative 3-day course of 500 mg daily for certain acute infections. Specific conditions, such as Chlamydia trachomatis, require a single dose of 1 g. For oral forms, the tablets and standard suspension can be taken with or without food.

Procedural Instructions and Constraints

The IV formulation must be reconstituted from a powder and subsequently diluted before being administered as a controlled infusion over a duration of one to three hours; it must not be given as a bolus or an intramuscular injection. For infections initially treated with IV azithromycin, the therapy is typically transitioned to oral dosing to complete a total course of 7 to 10 days.

Pediatric dosing is based on weight (mg/kg) and follows specific short-course regimens. If a daily dose is missed by 12 hours or less, it should be taken right away; otherwise, the missed dose is skipped, and the scheduled regimen is continued. No dosage adjustment is required for mild to moderate renal or hepatic impairment.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Amizin (Azithromycin)

Studies for Acute Respiratory and Ear Infections

Research evaluating the use of Azithromycin for Community-Acquired Pneumonia (CAP), Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB), and Acute Otitis Media (AOM) relies heavily on short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time and focused on endpoints describing episodic or acute changes and the elimination of the target bacteria. In studies for CAP and ABECB, studies reported on measurements of clinical status and changes in signs and symptoms after a short study period. For conditions like Pharyngitis or Tonsillitis, Azithromycin was studied for the elimination of specific bacteria. Research describes that its use was observed in populations where other agents were not suitable.


Research for Localized and Systemic Infections

Azithromycin was studied for both uncomplicated skin and soft tissue infections and certain uncomplicated genital infections. Short-course or single-dose regimens were evaluated in these research settings. For genital infections, research focused on the primary outcome of microbiological cure (the elimination of the organism). Findings describe group patterns observed in the studies related to these specific, uncomplicated conditions.


Evidence for Extended and Chronic Use

Azithromycin was evaluated in a different context for prevention or treatment of Disseminated Mycobacterium avium Complex (MAC) disease in patients with advanced HIV infection. Studies explored endpoints such as the frequency of new MAC disease cases (prevention) and metrics related to life expectancy (a study outcome). Azithromycin was observed in long-term trials for chronic lung conditions, such as COPD (Chronic Obstructive Pulmonary Disease), where studies monitored outcomes related to systemic or functional imbalance.


Key Research Gaps and Uncertainty

For most acute bacterial infections, the follow-up durations were limited. While these studies provide context but not individual predictions regarding the immediate outcome, information for long-term outcomes is often limited in the primary research studies. Studies monitored the long-term potential for antimicrobial resistance, which is a key research limitation. The comparative evidence is lacking against other available treatments for some indications, and data for certain groups remain insufficient.

Key Studies & References

  1. Label: AZITHROMYCIN tablet, film coated AZITHROMYCIN powder, for suspension - DailyMed (FDA-Authorized Information)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amizin (Azithromycin) (FAQ)

Q: What is the main reason Amizin (Azithromycin) is prescribed?

A: Official documents describe that Amizin (Azithromycin) is used for treating infections caused by susceptible bacteria. These commonly include respiratory tract infections, specific skin and soft tissue infections, and certain sexually transmitted infections. Prescribing is based on the identification of susceptible bacteria causing the infection.

Q: Is Amizin a type of penicillin?

A: No. According to official drug information, Amizin (Azithromycin) is classified as a macrolide antibiotic. It is chemically distinct from penicillin. Since it belongs to a different class of medicine, it is generally considered an option for individuals with a known penicillin allergy, based on professional judgment.

Q: What are some of the most common side effects listed for Amizin?

A: The most commonly reported adverse reactions described in regulatory documents are related to the gastrointestinal system. These typically include nausea, vomiting, abdominal pain, and diarrhea. Official sources contain a comprehensive list of reported adverse reactions.

Q: Does Amizin (Azithromycin) cause diarrhea?

A: Yes, official drug information lists diarrhea as one of the most common adverse reactions. Severe or persistent diarrhea that occurs during or even after treatment may be a sign of a more serious intestinal infection and requires consultation with a healthcare professional.

Q: Is it common to feel tired while taking Azithromycin?

A: Fatigue (tiredness) is mentioned in official drug information documents as a reported, though generally less frequent, adverse reaction. Other central nervous system effects like headache and dizziness are also sometimes reported.

Q: Can Amizin (Azithromycin) interact with birth control pills?

A: Official medical information states that Azithromycin does not typically stop hormonal contraceptives, such as birth control pills, from working. However, if the medication causes severe vomiting or diarrhea for an extended period (more than 24 hours), the reliable action of the contraceptive may be reduced.

Q: Can older adults use Amizin (Azithromycin)?

A: Regulatory documents generally do not require a specific dose adjustment for elderly patients. Official guidance describes that caution is generally warranted because older adults may be more susceptible to the drug’s potential effect on the heart's electrical rhythm, known as QT interval prolongation.

Q: What are the concerns about taking Amizin (Azithromycin) if someone has a heart condition?

A: Regulatory warnings describe that this medicine can cause changes in the heart's electrical activity. This change is associated with a risk of serious irregular heart rhythms, such as torsades de pointes. This risk is described as being greater in people who already have pre-existing heart conditions.

Q: Is Amizin (Azithromycin) considered a broad-spectrum antibiotic?

A: Yes, authoritative sources often describe Azithromycin as a broad-spectrum macrolide antibiotic. This classification is due to its documented antibacterial activity against a wide range of susceptible Gram-positive and Gram-negative bacteria.

Q: Can I use over-the-counter pain relievers while taking Amizin?

A: Official drug interaction lists provide specific warnings for medicines that prolong the heart's QT interval. While common non-prescription pain relievers are generally not listed as clinically significant interactions, patients are generally advised to inform their healthcare professional about all medicines being taken.

Q: Are there any known long-term side effects from using Azithromycin?

A: Most official documents focus on short-term use for acute infections. However, research exploring long-term use in specific chronic conditions has monitored the long-term potential for developing antimicrobial resistance and possible, though rare, hearing impairment over extended periods.

Q: Is it safe to drive after taking Amizin (Azithromycin)?

A: Official patient information states that Azithromycin may cause side effects like dizziness or drowsiness (somnolence) in some individuals. If these effects occur, official guidance states that activities like driving or operating complex machinery should be avoided.

Q: What is the connection between Amizin (Azithromycin) and hearing changes?

A: Official drug information lists hearing disturbances as reported adverse reactions. These disturbances can include hearing loss (sometimes temporary), deafness, and/or tinnitus (ringing in the ears).

Q: Can Azithromycin be used to treat viral infections?

A: According to official indications, Amizin (Azithromycin) is a medicine intended for the treatment of infections caused by susceptible bacteria. Regulatory documents state that prescribing it when there is no proven bacterial infection provides no benefit and increases the risk of developing drug-resistant bacteria.

Q: Is the rash that sometimes occurs a sign of a serious reaction to Amizin?

A: Official documents warn that serious allergic and dermatologic reactions, including severe skin conditions, have been reported with this medicine. A rash can be a symptom of these serious reactions, sometimes accompanied by fever or swelling, and is a reason for immediate consultation with a healthcare professional.

Q: Do any official documents describe Azithromycin's use for treating acne?

A: The official drug label for Azithromycin does not include acne vulgaris as an approved indication. Its use for this condition is considered off-label, meaning it is not a use included in the main regulatory approval.

Q: Why do doctors often prescribe Amizin (Azithromycin) for chest infections?

A: Official indications for Azithromycin include the treatment of certain respiratory tract infections. This includes conditions such as Community-Acquired Pneumonia (CAP) and acute bacterial exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

Q: Are there different strengths or formulations of Amizin (Azithromycin)?

A: Yes, official documents describe that Amizin (Azithromycin) is available in several dosage forms and strengths. These commonly include oral tablets (e.g., 250 mg and 500 mg), oral suspension (liquid), and a powder for intravenous injection.

Q: Is it possible to be allergic to Amizin (Azithromycin) even if I've taken it before?

A: Official warnings describe that serious allergic reactions have been reported in patients on Azithromycin therapy. Since an allergy can occur after a previous exposure that did not cause a reaction, prior tolerance does not rule out the possibility of a future reaction.

Q: What are the official safety classifications for Amizin (Azithromycin) during pregnancy?

A: Official documents advise that Amizin (Azithromycin) should only be used during pregnancy if clearly needed. The use of the medicine is recommended only when the potential benefit is judged by a healthcare professional to outweigh the potential risk to the fetus.

Q: Do official sources mention any potential vision changes with Amizin use?

A: Official drug safety information lists reports of visual disturbances as a possible, though uncommon, adverse reaction. If changes in vision occur, professional evaluation is recommended.

Q: What happens if someone accidentally takes too much Amizin?

A: In cases of taking too much medicine (overdosage), official information describes symptoms such as severe nausea, vomiting, and diarrhea. Regulatory guidance and case reports also link overdose to a potential risk of more serious effects on the heart's electrical rhythm, and the situation requires immediate medical attention.

Q: When should I stop taking Amizin (Azithromycin)?

A: Regulatory guidance emphasizes that the full course of treatment should be completed as prescribed, even if symptoms improve. Discontinuation of the drug is generally advised only when directed by a healthcare professional, typically if a serious adverse reaction occurs.

Q: Is Amizin (Azithromycin) commonly used to treat sexually transmitted infections (STIs)?

A: Official indications for Azithromycin include the treatment of certain sexually transmitted infections. Specifically, it is approved for uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis and certain cases of Neisseria gonorrhoeae, and for genital ulcer disease.

Q: Can the taste in the mouth change while taking Azithromycin?

A: Yes, official adverse reaction reports list taste perversion or a change in the sense of taste (dysgeusia) as a possible side effect of Azithromycin. This effect is generally temporary and resolves after the treatment course is finished.

Q: Is it normal for side effects to continue after stopping Amizin?

A: Due to the medicine's long tissue half-life, official documents note that some side effects, like allergic symptoms, have recurred in patients even after the drug was discontinued. This is why prolonged observation is described in some official documents.

Q: Does Amizin (Azithromycin) affect blood sugar levels?

A: Official clinical trial results have described both decreased blood glucose and elevated blood glucose levels as clinically significant laboratory abnormalities in some patients taking Azithromycin.

Q: What are the official guidelines regarding Azithromycin and sun exposure?

A: Some authoritative sources advise patients to limit sun exposure, avoid tanning beds, and use sun protection while taking Azithromycin. This precaution is described in some authoritative sources because the medicine may potentially increase sensitivity to the sun (photosensitivity).

Q: Does taking Amizin (Azithromycin) make you feel drowsy?

A: Drowsiness (somnolence) and dizziness are listed in official documents as potential, though uncommon, adverse effects of Azithromycin. If these effects occur, activities like driving should be performed with caution.

Q: Are there specific symptoms that mean I should stop taking Amizin immediately?

A: Official warnings describe that discontinuation is typically warranted if symptoms occur. These include signs of a serious allergic reaction (e.g., swelling, severe blistering rash), signs of liver problems (e.g., yellowing of the skin/eyes, dark urine), or fast/irregular heartbeats.

Q: How is Amizin (Azithromycin) classified by official health bodies?

A: Azithromycin is classified by official health bodies as an azalide, which is a subclass of the macrolide class of antibiotics. This classification is based on its specific chemical structure and mechanism of action.

Q: What is the risk of developing antibiotic resistance with Azithromycin use?

A: Regulatory guidance advises that to reduce the development of drug-resistant bacteria, Azithromycin should only be prescribed in the presence of a proven or strongly suspected bacterial infection. Inappropriate use increases the risk of resistance.

Q: Are there any documented interactions between Amizin and herbal supplements?

A: Official documents do not typically list specific herbal supplements as tested interactions. However, general safety guidance advises patients to always inform their healthcare professional about all other products taken, including vitamins and herbal supplements, as there is generally limited data available on the effects of these combinations.

Q: Can Amizin (Azithromycin) make existing mental health conditions worse?

A: Official adverse reaction reports include psychiatric disorders, such as anxiety and nervousness, as possible effects. Regulatory information does not specifically state the worsening of pre-existing mental health conditions but lists these as potential adverse effects.

Q: How long do the effects of Amizin (Azithromycin) last in the body?

A: The prolonged presence of the compound is described in official pharmacokinetic properties by its long terminal elimination half-life, which is approximately 68 hours. This characteristic is linked to its extensive accumulation within the body's tissues and subsequent slow release.

Q: Is Amizin (Azithromycin) the same as Z-Pak?

A: Z-Pak is a specific brand name formulation of the active ingredient Azithromycin. The term Z-Pak refers to a specific pre-packaged 5-day course, which is one common regimen for the medicine.

Q: Are there specific foods I should avoid while on Amizin?

A: For most oral forms of the medicine, regulatory documents state that the medication can be taken with or without food. The medicine's official label does not list any specific foods that must be strictly avoided during treatment.

Q: What happens if I miss a dose of Amizin?

A: Official procedural information states that if a daily dose is missed by 12 hours or less, it should be taken immediately. If the time elapsed is more than 12 hours, the missed dose is typically skipped, and the patient continues with the next scheduled dose.

Q: What is the research evidence about Amizin (Azithromycin) use in children?

A: The drug is approved for use in children for specific infections (like acute otitis media), and pediatric dosing is based on the child's weight. Regulatory documents also include a safety warning regarding a rare condition called Infantile Hypertrophic Pyloric Stenosis (IHPS) following use in neonates.

Q: What is the difference between Amizin (Azithromycin) and clarithromycin?

A: Both are macrolide antibiotics, but authoritative sources describe that Azithromycin exhibits limited interaction with the liver's cytochrome P450 enzyme system, unlike clarithromycin and erythromycin. This difference can impact the risk of interaction with other medications.

Advertisements

How should Amizin (Azithromycin) be stored and disposed of?

Storage and Disposal of Azithromycin

Official labeling defines precise storage and disposal requirements for Azithromycin to ensure stability and proper handling.


Storage and Stability

  • Tablets and Dry Powder: Store at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F). The dry powder should be kept in a tightly closed container and protected from excessive moisture.
  • Liquid Suspension: The reconstituted liquid MUST NOT be refrigerated and must be stored at or below 30 C (86 F). It must be discarded after 5 days (or 12 hours for the 2g single dose).
  • Child Safety: Keep the medicine out of the sight and reach of children.

Disposal

Any unused liquid suspension MUST be discarded according to the stability rules. Do not dispose of via wastewater or household waste. Unused product should be returned to a pharmacy or disposed of following local regulatory requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amizin (Azithromycin) found in:

A-Z Index: